Packaging a drug in a prefilled syringe may help extend a product's patent and distinguish it from competing products. Prefilled syringes have gained popularity among patients and healthcare providers ...

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). The ...

GSK has received the Food and Drug Administration’s approval for a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).

The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...

Please provide your email address to receive an email when new articles are posted on . The original formulation of Shingrix consists of two separate vials combined by health care workers prior to ...

The new prefilled syringe simplifies the vaccine administration process as the existing vaccine consists of two vials that health care professionals must combine before administration. HealthDay News ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to increase adult vaccination against shingles (herpes zoster). FDA approves ...